124 related articles for article (PubMed ID: 29171987)
1. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.
Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987
[TBL] [Abstract][Full Text] [Related]
2. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.
Feng R; Beeharry MK; Lu S; Sah BK; Yuan F; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 22(1):119-126. PubMed ID: 29562500
[TBL] [Abstract][Full Text] [Related]
4. MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk.
Li X; Wang F; Qi Y
Eur Rev Med Pharmacol Sci; 2014; 18(14):2031-7. PubMed ID: 25027343
[TBL] [Abstract][Full Text] [Related]
5. miR-126 functions as a tumour suppressor in human gastric cancer.
Feng R; Chen X; Yu Y; Su L; Yu B; Li J; Cai Q; Yan M; Liu B; Zhu Z
Cancer Lett; 2010 Dec; 298(1):50-63. PubMed ID: 20619534
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
8. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
Shi YX; Ye BL; Hu BR; Ruan XJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
11. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
Cui Z; Zheng X; Kong D
World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
Ma G; Dai W; Sang A; Yang X; Gao C
Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of microRNA-126 and CRK expression in gastric cancer.
Yue S; Shi H; Han J; Zhang T; Zhu W; Zhang D
Onco Targets Ther; 2016; 9():6127-6135. PubMed ID: 27785060
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
17. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of miR-302a/b/c/d in Human Gastric Cancer.
Ma G; Li Q; Dai W; Yang X; Sang A
Pathol Oncol Res; 2017 Oct; 23(4):899-905. PubMed ID: 28795345
[TBL] [Abstract][Full Text] [Related]
19. Tumor Expression of
Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O
Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733
[TBL] [Abstract][Full Text] [Related]
20. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
